These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34092049)

  • 1. Impact of urgently initiated tele-prescription due to COVID-19 on glycemic control in patients with type 2 diabetes.
    Park SD; Kim NY; Jeon JH; Kim JG; Lee IK; Park KG; Choi YK
    Korean J Intern Med; 2021 Jul; 36(4):942-948. PubMed ID: 34092049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus.
    Park SD; Kim SW; Moon JS; Lee YY; Cho NH; Lee JH; Jeon JH; Choi YK; Kim MK; Park KG
    Diabetes Metab J; 2021 Jan; 45(1):109-114. PubMed ID: 33264833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Year-Long Trend in Glycated Hemoglobin Levels in Patients with Type 2 Diabetes during the COVID-19 Pandemic.
    Jin J; Lee SW; Lee WK; Jeon JH; Kim JG; Lee IK; Choi YK; Park KG
    Endocrinol Metab (Seoul); 2021 Oct; 36(5):1142-1146. PubMed ID: 34674507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the COVID-19 pandemic on the glycemic control in people with diabetes mellitus: A retrospective cohort study.
    Ohkuma K; Sawada M; Aihara M; Doi S; Sekine R; Usami S; Ohe K; Kubota N; Yamauchi T
    J Diabetes Investig; 2023 Aug; 14(8):985-993. PubMed ID: 37118898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.
    Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M
    BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study.
    Hayek S; Ben-Shlomo Y; Balicer R; Byrne K; Katz M; Kepten E; Raz I; Roitman E; Zychma M; Barda N
    Diabetes Obes Metab; 2021 Aug; 23(8):1995-2000. PubMed ID: 33822446
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Control and Mucormycosis during COVID-19 Pandemic in India a Study of Stage and Outcome.
    Sharma V; Kriplani K; Tuli IP; Sharma S; Narula A
    J Assoc Physicians India; 2023 Sep; 71(9):61-66. PubMed ID: 38700303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002.
    Fox KM; Gerber Pharmd RA; Bolinder B; Chen J; Kumar S
    Clin Ther; 2006 Mar; 28(3):388-95. PubMed ID: 16750453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus in Dubai.
    Makki I; Alnoon N; Rahmani N; Almulla J; Alamiri A; Alfalasi A; Zidan M
    Curr Diabetes Rev; 2022; 18(8):e081221198650. PubMed ID: 34879807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan.
    Endo K; Miki T; Itoh T; Kubo H; Ito R; Ohno K; Hotta H; Kato N; Matsumoto T; Kitamura A; Tamayama M; Wataya T; Yamaya A; Ishikawa R; Ooiwa H
    Intern Med; 2022; 61(1):37-48. PubMed ID: 34980759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes.
    Tannus LRM; Zapelini RM; Cabizuca CA; Abi-Abib RC; Matheus ASM; Calassara PC; Pozzan R; Cobas RA
    Endocrine; 2022 Sep; 77(3):455-460. PubMed ID: 35838896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus.
    Chen S; Shen Y; Liu YH; Dai Y; Wu ZM; Wang XQ; Yang CD; Li LY; Liu JM; Zhang LP; Shen WF; Ji R; Lu L; Ding FH
    Cardiovasc Diabetol; 2021 Mar; 20(1):64. PubMed ID: 33714276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.
    Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N
    Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on the glycemic control, eating habits, and body compositions of people with diabetes mellitus: A retrospective longitudinal observational study.
    Sawada M; Ohkuma K; Aihara M; Doi S; Sekine R; Kaneko T; Iimuro S; Ichi I; Usami S; Ohe K; Yamauchi T; Kubota N
    J Diabetes Investig; 2023 Feb; 14(2):321-328. PubMed ID: 36346131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
    Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
    Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.